Grundinformationen
- Standard-SMILES
CCC(C)(C)c1ccc(CC(C)CN2C[C@@H](C)O[C@@H](C)C2)cc1- InChIKey
MQHLMHIZUIDKOO-AYHJJNSGSA-N- Summenformel
- C21H35NO
- Durchschnittliche Molmasse
- 317,5 g/mol
- Monoisotopische Masse
- 317,27186474
Überblick
Amorolfine is a member of the class of morpholines that is cis-2,6-dimethylmorpholine in which the hydrogen attached to the nitrogen is replaced by a racemic 2-methyl-3-[p-(2-methylbutan-2-yl)phenyl]propyl group. An inhibitor of the action of squalene monooxygenase, 14 reductase and D7-D8 isomerase and an antifungal agent, it is used (generally as its hydrochloride salt) for the topical treatment of fungal nail and skin infections. It has a role as an EC 1.14.13.132 (squalene monooxygenase) inhibitor, an EC 1.3.1.70 (Delta(14)-sterol reductase) inhibitor and an EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor. It is a tertiary amino compound and a morpholine antifungal drug. It is a conjugate base of an amorolfine(1+).
Namen und Bezeichner
- Bevorzugter Name
- Amorolfine
- IUPAC
- (2S,6R)-2,6-dimethyl-4-[2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
67467-83-8、78613-35-1- PubChem CID
- 54260
- DTXSID
DTXSID0046690- ChEMBL
CHEMBL489411- ChEBI
CHEBI:599440- Nikkaji
- J389.118F
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 5,7
- Polarare Oberfläche (TPSA)
- 12,5 Ų
- H-Brücken-Donoren
- 0
- H-Brücken-Akzeptoren
- 2
- Frei drehbare Bindungen
- 6
- Schwere Atome
- 23
- Formalladung
- 0
- Komplexität
- 336
Sicherheit und Regulatorisches
Gefahrenhinweise
Regulatory Information
Morpholine, 4-3-4-(1,1-dimethylpropyl)phenyl-2-methylpropyl-2,6-dimethyl-, (2R,6S)-rel-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Chemie und Industrie
Pharmakologische Informationen
ATC Code
D01AE16
D - Dermatologicals
QD - Dermatologicals
Mechanism of Action
Amorolfine mediates its antifungal effects by interfering with ergosterol biosynthesis in the fungal cell membrane by inhibiting delta(14)-sterol reductase and cholestenol delta-isomerase. It alters the membrane sterol content, thereby changing the membrane permeability and disrupting metabolic processes.
Verwendung und Herstellung
Zugehörige Reaktionen
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Verknüpfte Notizen
Wird geladen…